Navigation Links
Predicting the future for patients with severe traumatic brain injury
Date:11/17/2008

This release is available in French.

Montreal, November 17th, 2008 "How will our loved one come out of this?" After an accident that results in severe traumatic brain injury (sTBI), the answer to this simple question can change everything for a family.

The latest study carried out by Dr. Elaine deGuise, Joanne Leblanc, Mitra Feyz and all the clinicians of the Traumatic Brain Injury Program for Adults at the McGill University Health Centre (MUHC) describes the tools that are most effective at providing an objective answer to this question almost as soon as patients leave intensive care. The study was published recently in the Journal of Head Trauma Rehabilitation.

Better advice and more structured follow-up

"This study is unique as it involved a multidisciplinary team. We could therefore assess the patient from many angles and establish an overall picture," stated Dr. deGuise. "Our findings are important because, in addition to the advice that we can give to families, we can now implement a comprehensive program in the continuum of care that is based on more objective and scientific principles."

Powerful predictive tools

When patients with a sTBI leave acute care hospitals (generally between 20 to 29 days after the accident), they undergo standard tests to assess their overall level of functioning and to orientate them to appropriate resources to optimize their recovery.

This study proves that their results can also be used to predict the future development of the patient's general condition. The tests used in this study include the GOS-E (Extended Glasgow Outcome Scale), the NRS-R (Neurobehavioral Rating Scale-Revised), and the FIM (Functional Independence Measure).

"The tests that are regularly performed on all our patients with a sTBI are very effective tools as, based on th
'/>"/>

Contact: Isabelle Kling
isabelle.kling@muhc.mcgill.ca
514-843-1560
McGill University Health Centre
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Novel imaging approach may assist in predicting success of treatment for atrial fibrillation
2. Prototype test for predicting clinical outcome for melanoma patients
3. Research highlights problems of predicting birthweights in obese mothers
4. Predicting post-traumatic stress disorders in deployed veterans
5. Predicting the future in ovarian cancer
6. Predicting survival after liver transplantation
7. Blood test takes step toward predicting Alzheimers risk, Stanford researchers find
8. Use of certain lipid measures not more effective in predicting coronary heart disease
9. Future Looks Bright For Non-Invasive Diagnosis Of Skin Cancer; Study Shows Novel Light Device Detects Cancerous Lesions From Normal Tissue
10. FutureScripts(R) Wins Business of UFCW Local 1776 for Pharmacy Benefits
11. Experts discuss future of public health research on Down syndrome

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...les may reduce future disease burden, researchers ... -- Encouraging city dwellers to walk and bicycle ...lic health benefits than increased used of low-emi...The study compared the projected health effects in...s for London, England, and Delhi, India: business...
(Date:11/27/2009)...ingual coloring books designed for children ages 2... to educate - inform parents and children alike on...uars to ABC,S and a host of other topics. , ...r 27, 2009 -- Today’s children have enough g...hour of the day, but one of the oldest and simples...
(Date:11/26/2009)...ewswire/ -- The diabetes population in the United ...nd annual medical spending on the disease is proje...ay, according to a study published in the December... Diabetes ® Program (NCDP), a program of Novo... the University of Chicago. ,, According to the...
(Date:11/26/2009)...al rollercoaster, study finds , , THURSD...actor meets the jubilant sports fan. , A new st...ho root for the winning team -- enjoy the greatest...d victory was in doubt, producing feelings of worr...iving weekend as you,re glued to the TV set, watch...
(Date:11/26/2009)...ions announces a highly effective and unconvention... to make an economic recovery. , ...the type of challenge that could send ailing holid...avid Benton, business growth expert and author of ... The Rfactor Intensive . “Fear is one of t...
Breaking Medicine News(10 mins):Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 4Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Pharmacist Injects Cure for Ailing Businesses 2
...s by American scientists has revealed a startling ...opean descent have DNA that is linked to// the ris...ll. These genes lie close to another set that is... if they do not have clear risk factors such as sm...
...can doctor has threatened to mobilise US congressm... him information// under the Right to Information ...t the corrupt healthcare system here. Kunal...sk them to raise this issue with the Indian govern...
...an Resource Development in collaboration with Nati... an educational programme,// known as Adolescence ...ed by all the States and Union Territories of the ...ng up during adolescence, HIV/AIDS and drug (subst...
...tudents here have developed a device that can enab.../. Called 'E-Netra', it costs Rs.2,000-3,000 ...converts them into voice that can be heard through...six months to develop the device and the software ...
...c technology to detect epidemic diseases has enter...inese scientist//. Different from traditiona...he new technology is based on genetic substances o... of US National Institutes of Health (NIH). ...
... women who consumed higher levels of calcium and v...ater volumes of brain lesions, regions of damage//...ementia, depression and stroke. Dr. Payne a... 153 women) between the ages of 60 and 86 (average...
Other Medicine News:Health News:Gene Mutations Leave Caucasians Prone To Heart Diseases And Diabetes 2Health News:NRI Threatens to Move US Congress for Justice in India 2Health News:Higher Intake of Calcium and Vitamin D Linked With Brain Lesions in Older People 2
(Date:11/25/2009)...wire-FirstCall/ -- ERT (Nasdaq: ERES ), announced... President and CEO, and Keith Schneck, the Company... to present at the 21st Annual Piper Jaffray Healt...09 in New York City, New York. ,, Interested pa...Company,s corporate website at http://www.ert.com...
(Date:11/25/2009)...ire/ -- The FDA granted traditional approval for I...ide reverse transcriptase inhibitor (NNRTI). INTEL...use in treatment-experienced adults who are experi...ant to an NNRTI and other antiretroviral (ARV) age... data from two Phase 3 studies known as DUET-1 and...
(Date:11/25/2009)...RNewswire/ -- AMPAC Fine Chemicals LLC (AFC), a su... APFC ) announced today that it received the Envir...t the Annual Statewide Environmental Summit, spons...y Association (CMTA), the Industrial Environmental...il of California (CICC) held in San Diego. This i...
Breaking Medicine Technology:ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 5AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 3Stem Cells Grow Heart Tissue in Lab 59556 1Stem Cells Grow Heart Tissue in Lab 59556 2Stem Cells Grow Heart Tissue in Lab 59556 3Medical Transcription Services Provider MxSecure Names Healthcare IT Expert Mark McLaughlin New Chief Technology Officer 59553 1Medical Transcription Services Provider MxSecure Names Healthcare IT Expert Mark McLaughlin New Chief Technology Officer 59553 2Medical Transcription Services Provider MxSecure Names Healthcare IT Expert Mark McLaughlin New Chief Technology Officer 59553 3Astrup Drug Implements ECRS Retail Solution Suite to Address Diverse Business Requirements 59550 1Astrup Drug Implements ECRS Retail Solution Suite to Address Diverse Business Requirements 59550 2
...inary Phase II Results Encouraging and Support Pha...ternational,Inc. (NYSE: BAX ) and The Alzheimer,s...unced the decision to pursue a multi-center U.S. P...quid [Immune Globulin Intravenous,(Human)] (IGIV),...e,treatment of patients with mild to moderate alzh...
...rack to have Phase 3 data available by the spring ...tion applications expected by the ...28 Human Genome,Sciences, Inc. (Nasdaq: HGSI ) t...d initial dosing ahead of schedule in ACHIEVE 1, t...n(R) (albinterferon alfa-2b) in,combination with r...
Other Medicine Technology:Baxter and The Alzheimer's Disease Cooperative Study Group to Pursue a Phase III Study of Gammagard Liquid in Patients With Alzheimer's Disease 2Baxter and The Alzheimer's Disease Cooperative Study Group to Pursue a Phase III Study of Gammagard Liquid in Patients With Alzheimer's Disease 3Baxter and The Alzheimer's Disease Cooperative Study Group to Pursue a Phase III Study of Gammagard Liquid in Patients With Alzheimer's Disease 4Baxter and The Alzheimer's Disease Cooperative Study Group to Pursue a Phase III Study of Gammagard Liquid in Patients With Alzheimer's Disease 5Baxter and The Alzheimer's Disease Cooperative Study Group to Pursue a Phase III Study of Gammagard Liquid in Patients With Alzheimer's Disease 6Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule 2Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule 3Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule 4Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule 5
CX41 Microscopes
CX31 Microscopes
...designed from the ground-up with ergonomic concern...justable observation tube on the market. Optional ...every user can adjust the microscope to suit their...s the operator maintain an upright, comfortable po...
Eclipse TS100F
Medicine Products: